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Interneurons in the Superﬁcial Dorsal Horn of the Mouse Spinal Cord that
Respond to Noxious and Pruritic Stimuli
Maria Gutierrez-Mecinas,a,1 Andrew Bell,a,1 Erika Polgár,a Masahiko Watanabeb and Andrew J. Todda,⁎
aInstitute of Neuroscience and Psychology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK
bDepartment of Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, JapanAbstract—The great majority of neurons in the superﬁcial dorsal horn of the spinal cord are excitatory interneurons,
and these are required for the normal perception of pain and itch. We have previously identiﬁed 5 largely non-
overlapping populations among these cells, based on the expression of four different neuropeptides (cholecystokinin,
neurotensin, neurokinin B and substance P) and of green ﬂuorescent protein driven by the promoter for gastrin-
releasing peptide (GRP) in a transgenic mouse line. Another peptide (neuropeptide FF, NPFF) has been identiﬁed
among the excitatory neurons, and here we have used an antibody against the NPFF precursor (pro-NPFF) and a probe
that recognises Npff mRNA to identify and characterise these cells. We show that they are all excitatory interneurons,
and are separate from the ﬁve populations listed above, accounting for ~6% of the excitatory neurons in laminae I-II. By
examining phosphorylation of extracellular signal-regulated kinases, we show that the NPFF cells can respond to dif-
ferent types of noxious and pruritic stimulus. Ablation of somatostatin-expressing dorsal horn neurons has been
shown to result in a dramatic reduction in mechanical pain sensitivity, while somatostatin released from these neurons
is thought to contribute to itch. Since the great majority of the NPFF cells co-expressed somatostatin, these cells may
play a role in the perception of pain and itch. © 2019 The Author(s). Published by Elsevier Ltd on behalf of IBRO. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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The superﬁcial dorsal horn (laminae I-II) of the spinal cord
receives excitatory synaptic input from primary sensory
neurons that detect noxious, thermal and pruritic stimuli,
and this information is conveyed to the brain via projection
neurons belonging to the anterolateral tract (ALT) (Todd,
2010; Braz et al., 2014). Although the projection cells are
concentrated in lamina I, they only account for ~1% of theroup, Sir James Black Building,
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281neurons in the superﬁcial dorsal horn (Abraira et al., 2017;
Todd, 2017). The remaining nerve cells are deﬁned as inter-
neurons, and these have axons that remain within the spinal
cord, where they contribute to local synaptic circuits (Peirs
and Seal, 2016). Around 75% of the interneurons in laminae
I-II are excitatory cells that use glutamate as their principal
fast transmitter (Polgár et al., 2013). Behavioural assess-
ment of mice in which excitatory interneurons in laminae I-
II have been lost indicate that these cells are essential for
the normal expression of pain and itch (Wang et al., 2013;
Duan et al., 2014). However, the excitatory interneurons
are heterogeneous in terms of their morphological, electro-
physiological and neurochemical properties, and this has
made it difﬁcult to assign them to distinct functional popula-
tions (Todd, 2017).
We have identiﬁed 5 largely non-overlapping neurochem-
ical populations among the excitatory interneurons in lami-
nae I-II of the mouse spinal cord (Gutierrez-Mecinas et al.,
2016, 2017, 2019). Cells belonging to 3 of these popula-
tions, which are deﬁned by expression of neurotensin, neu-
rokinin B (NKB, encoded by the Tac2 gene) andan open access article under the CC BY license (http://creativecommons.org/
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lamina II, and extend into lamina III. These cells frequently
co-express the γ isoform of protein kinase C (PKCγ). The
other two populations consist of: (1) cells that express
enhanced green ﬂuorescent protein (eGFP) under control
of the promoter for gastrin-releasing peptide (GRP) in a
BAC transgenic mouse line (GRP-EGFP), and (2) cells that
express the Tac1 gene, which codes for substance P
(Dickie et al., 2019). The GRP-eGFP and substance P cells
are located somewhat more dorsally than the other three
populations, in the mid-part of lamina II. We have estimated
that between them, these 5 populations account for around
two-thirds of the excitatory interneurons in the superﬁcial
dorsal horn (Gutierrez-Mecinas et al., 2016, 2017, 2019).
Our ﬁndings are generally consistent with the results of a
recent transcriptomic study (Häring et al., 2018), which iden-
tiﬁed 15 clusters (named Glut1–15) among dorsal horn exci-
tatory neurons. These included cells enriched with mRNAs
for CCK (Glut1–3), neurotensin (Glut4), Tac2 (Glut5–7)
and Tac1 (Glut10–11).
Another cluster identiﬁed by Häring et al. consisted of
cells with mRNA for neuropeptide FF (NPFF; Glut9). Pre-
vious studies had identiﬁed NPFF-expressing cells in the
superﬁcial dorsal horn of rat spinal cord by using immu-
nocytochemistry with anti-NPFF antibodies (Allard et al.,
1991; Kivipelto and Panula, 1991). Both of these studies
revealed a dense plexus of NPFF-immunoreactive axons
in lamina I and the outer part of lamina II, which extended
into the lateral spinal nucleus (LSN), together with scat-
tered ﬁbres in other regions including the intermediolateral
cell column and the area around the central canal.
Kivipelto and Panula (1991) also administered colchicine,
which resulted in NPFF staining in cell bodies, and these
were located throughout laminae I and II.
The aim of the present study was to identify and charac-
terise NPFF-expressing cells in the mouse, by using a
new antibody directed against the precursor protein pro-
NPFF. In particular, our goal was to conﬁrm that these were
all excitatory interneurons and determine what proportion
they accounted for, and to test the hypothesis that they
formed a population that was distinct from those that we
had previously identiﬁed. We also assessed their
responses to different noxious and pruritic stimuli by testing
for phosphorylation of extracellular signal-regulated
kinases (ERK) (Ji et al., 1999).EXPERIMENTAL PROCEDURES
Animals
All experiments were approved by the Ethical Review Pro-
cess Applications Panel of the University of Glasgow, and
were performed in accordance with the European Commu-
nity directive 86/609/EC and the UK Animals (Scientiﬁc Pro-
cedures) Act 1986.
We used three genetically modiﬁed mouse lines during
the course of this study. One was the BAC transgenic Tg
(GRP-EGFP) in which enhanced green ﬂuorescent protein
(eGFP) is expressed under control of the GRP promoter(Gong et al., 2003; Gutierrez-Mecinas et al., 2014; Solor-
zano et al., 2015). We have recently shown that virtually
all eGFP-positive cells in this line possess GRP mRNA,
although the mRNA is found in many cells that lack eGFP
(Dickie et al., 2019). We also used a line in which Cre
recombinase (fused to the ligand binding domain of the oes-
trogen receptor) is inserted into the Grpr locus (GRPR-
iCreERT2) (Mu et al., 2017), and this was crossed with the
Ai9 reporter line, in which Cre-mediated excision of a
STOP cassette drives expression of tdTomato. Both GRP-
EGFP and GRPRCreERT2; Ai9 mice were used for studies
that assessed phosphorylated extracellular signal-
regulated kinases (pERK) following noxious or pruritic sti-
muli. The use of GRPRCreERT2;Ai9 mice for some of these
experiments allowed us also to assess responses of
GRPR-expressing neurons, and this will be reported in a
separate study.
Four adult wild-type C57BL/6 mice of either sex (18–25 g)
and 3 adult GRP-EGFP mice of either sex (20–31 g) were
deeply anaesthetised (pentobarbitone, 20 mg i.p.) and per-
fused through the left cardiac ventricle with ﬁxative contain-
ing 4% freshly depolymerised formaldehyde in phosphate
buffer. Lumbar spinal cord segments were removed and
post-ﬁxed for 2 h, before being cut into transverse sections
60 μm thick with a vibrating blade microtome (Leica
VT1200, Leica Microsystems, Milton Keynes, UK). These
sections were used for stereological analysis of the propor-
tion of neurons that were pro-NPFF-immunoreactive, and
also to look for the presence of pro-NPFF in GRP-eGFP,
somatostatin-immunoreactive and Pax2-immunoreactive
cells.
In order to determine whether any of the pro-NPFF-
immunoreactive cells were projection neurons, we used tis-
sue from 3 male wild-type C57BL/6 mice (32–35 g) that had
received injections of cholera toxin B subunit (CTb) targeted
on the left lateral parabrachial area (LPb) as part of pre-
viously published study (Cameron et al., 2015). In all cases,
the CTb injection ﬁlled the LPb on the left side. Transverse
sections from the L2 segments of these mice, which had
been ﬁxed as described above, were used for this part of
the study.
To look for evidence that pro-NPFF cells responded to
noxious or pruritic stimuli, we performed immunostaining
for pERK (Ji et al., 1999) on tissue from GRPRCreERT2;Ai9
or GRP-EGFP mice. Twelve GRPRCreERT2;Ai9 female mice
(17–23 g) were used to investigate responses to pinch or
intradermally injected pruritogens, and in all cases, this
was carried out under urethane anaesthesia (40–60 mg
urethane i.p.). For 3 of the mice, ﬁve skin folds on the left
calf were pinched for 5 s each (Dickie et al., 2019), and after
5 min, the mice were perfused with ﬁxative as described
above. The remaining mice received intradermal injections
of histamine (100 μg/10 μl PBS; 3 mice), chloroquine
(100 μg/10 μl PBS; 3 mice) or vehicle (10 μl PBS; 3 mice)
into the left calf, which had been shaved the day before.
The success of the intradermal injections was veriﬁed by
the presence of a small bleb in the skin (Roberson et al.,
2013). We have previously shown that intradermal injec-
tions of vehicle result in pERK labelling if mice are allowed
Table 1. Antibodies used in this study.
Antibody Species Catalogue no Dilution Source
pro-NPFF Guinea pig 0.83 μg/
ml
M Watanabe
NeuN Mouse MAB377 1:500 Merck
eGFP Chicken ab13970 1:1000 Abcam
Pax2 Rabbit HPA047704 1:200 Sigma
Somatostatin Rabbit T-4103 1:1000 Peninsula
CTb Goat 703 1:1000 List Biological
pERK Rabbit 9101 1:500 Cell Signalling
Technology
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noxious mechanical stimulus resulting from i.d. injection
(Bell et al., 2016). However, if the mice survive 30 mins,
pERK is seen in pruritogen-injected, but not vehicle-
injected animals, and this presumably reﬂects prolonged
activation by the pruritogens. We therefore waited until 30
mins after the injections before intracardiac perfusion with
ﬁxative, which was carried out as described above. Tissue
from 6 urethane-anaesthetised GRP-EGFP mice that had
had the left hindlimb immersed in water at 52 °C for 15 s
or had received a subcutaneous injection of capsaicin
(10 μl, 0.25%) was also used. In these cases, the tissue
was obtained from experiments that had formed part of a
previously published study (Dickie et al., 2019), and injec-
tion of the vehicle for capsaicin had been shown to result
in little or no pERK labelling. Capsaicin had initially been
prepared at 1% by dissolving it in a mixture of 7% Tween
80 and 20% ethanol in saline. It was then diluted to 0.25%
before injection.
Fluorescent in situ hybridisation was performed on lumbar
spinal cord sections from 3 C57BL/6 mice (either sex, 18-
20 g), tissue from which had been used in a previous study
(Gutierrez-Mecinas et al., 2019).
Immunocytochemistry, confocal scanning and
analysis
Multiple-labelling immunoﬂuorescence reactions were per-
formed as described previously (Gutierrez-Mecinas et al.,
2017) on 60 μm thick transverse sections of spinal cord.
The sources and concentrations of antibodies used are
listed in Table 1. Sections were incubated for 3 days atTable 2. RNAscope probes.
Probe Protein/peptide Ch
Npff Neuropeptide FF 2
Cck CCK 1
Grp Gastrin-releasing peptide 1
Nts Neurotensin 3
Tac1 Substance P 3
Tac2 NKB 3
RNAscope multiplex
positive control
(Polr2a, Ppib, Ubc)
Polr2a: DNA-directed RNA polymerase II
subunit RPB1; Ppib: Peptidyl-prolyl cis-trans
isomerase B; Ubc: Polyubiquitin-C
1,2
RNAscope multiplex
negative control (dapB)
dapB: 4-hydroxy-tetrahydrodipicolinate reductase
(derived from B Subtilis)
1,24 °C in primary antibodies diluted in PBS that contained
0.3 M NaCl, 0.3% Triton X-100 and 5% normal donkey
serum, and then overnight in appropriate species-speciﬁc
secondary antibodies (Jackson Immunoresearch, West
Grove, PA) that were raised in donkey and conjugated to
Alexa 488, Alexa 647, Rhodamine Red or biotin. All second-
ary antibodies were used at 1:500 (in the same diluent),
apart from those conjugated to Rhodamine Red, which were
diluted to 1:100. Biotinylated secondary antibodies were
detected with Paciﬁc Blue conjugated to avidin (1:1000; Life
Technologies, Paisley, UK). Following the immunocyto-
chemical reaction, sections were mounted in anti-fade med-
ium and stored at −20 °C.
Sections from 3 wild-type mice were reacted with the fol-
lowing combinations of primary antibodies: (1) pro-NPFF
and NeuN; (2) pro-NPFF, somatostatin and NeuN. Those
reacted with the ﬁrst combination were subsequently
stained with the nuclear stain 4′6-diamidino-2-phenylindole
(DAPI). Sections from 3 GRP-EGFP mice were reacted with
the following combination: pro-NPFF, eGFP, Pax2 and
NeuN. Sections from mice that had received injection of
CTb into the LPb were reacted with antibodies against
pro-NPFF, CTb and NeuN. Sections from mice that had
undergone the various types of noxious or pruritic stimula-
tion were reacted with antibodies against pro-NPFF, pERK
and NeuN.
Sections were scanned with a Zeiss LSM 710 confocal
microscope with Argon multi-line, 405 nm diode, 561 nm
solid state and 633 nm HeNe lasers. Confocal image
stacks were obtained through a 40× oil immersion lens
(numerical aperture 1.3) with the confocal aperture set to
1 Airy unit, and unless otherwise stated, the entire medio-
lateral width of laminae I-II was scanned to generate z-
series of at least 20 μm (and in many cases the full thick-
ness of the section), with a z-separation of 1 μm. Confocal
scans were analysed with Neurolucida for Confocal soft-
ware (MBF Bioscience, Williston, VT). The lamina II-III bor-
der was identiﬁed from the distribution of NeuN
immunoreactivity, based on the relatively low neuronal
packing density in lamina IIi. The lamina I-II border was
assumed to be 20 μm from the dorsal edge of the dorsal
horn (Ganley et al., 2015).
To determine the proportion of neurons in laminae I-II that
are pro-NPFF-immunoreactive, we used a modiﬁcation ofannel numbers Catalogue numbers Z-pair number Target region
479,901 9 47–433
402,271 12 23–679
317,861 15 22–825
420,441 20 2–1188
410,351 15 20–1034
446,391 15 15–684
,3 320,881 20
15
n/a
2802–3678
98–856
34–860
,3 320,871 10 414–862
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tions each from 3 wild-type mice reacted with the ﬁrst com-
bination of antibodies. The reference and look-up sections
were set 10 μm apart, and initially only the NeuN and
DAPI channels were viewed. All intervening optical sections
were examined, and neuronal nuclei (NeuN+/DAPI+ struc-
tures) were selected if their bottom surface lay between
the reference and look-up sections. These were plotted onto
an outline drawing of the dorsal horn. The pro-NPFF chan-
nel was then switched on and the presence or absence of
staining was determined for each of the selected neurons.
To estimate the extent of co-localisation of NPFF and
somatostatin, we scanned 2 sections that had been
reacted with the 2nd antibody combination from each of
3 wild-type mice. The pro-NPFF and NeuN channels
were viewed, and all pro-NPFF cells throughout the full
thickness of the section were identiﬁed. The somatostatin
channel was then switched on, and the presence or
absence of somatostatin in each selected cell was noted.
We searched for overlap between pro-NPFF and eGFP or
Pax2 in two sections each from three GRP-EGFP mice.
Again, all pro-NPFF-immunoreactive cells throughout the
depth of the section were initially identiﬁed, and the pre-
sence or absence of eGFP and Pax2 was then deter-
mined. To test whether any of the pro-NPFF cells were
projection neurons, we scanned and analysed between
4 and 7 sections from each of 3 mice that had received
CTb injections into the LPb (Cameron et al., 2015). We
identiﬁed all lamina I CTb + cells that were visible within
each section and checked for the presence of pro-NPFF-
immunoreactivity.
Analysis of ERK phosphorylation in pro-NPFF cells was
performed as described previously (Bell et al., 2016;
Gutierrez-Mecinas et al., 2017; Dickie et al., 2019). Sections
that contained numerous pERK+ cells were initially
selected and scanned with the confocal microscope through
the 40× oil-immersion lens to generate z-stacks (1 μm z-
separation) through the full thickness of the section so as
to include the region of dorsal horn that contained pERK
cells. The outline of the dorsal horn, together with the lamina
II/III border, was plotted with Neurolucida, and the mediolat-
eral extent of the region that contained a high density of pERK
cells was delineated by drawing two parallel lines that were
orthogonal to the laminar boundaries. The channels corre-
sponding to NeuN and pro-NPFF were initially viewed, and
all pro-NPFF+ cells within this region were plotted onto the
drawing. The pERK channel was then viewed, and the pre-
sence or absence of staining in each of the selected pro-
NPFF cells was noted.Fig. 1. Blocking of pro-NPFF immunostaining by pre-absorption with the
antigen. A: transverse section from the L3 segment of a mouse, reacted
with pro-NPFF antibody. Pro-NPFF-immunoreactivity (green) is super-
imposed on a dark-ﬁeld image (magenta). B: A section reacted with
pro-NPFF antibody that had been pre-absorbed overnight with 4.4 μg/
ml of antigen, and scanned under identical conditions. The immunor-
eactivity has been completely abolished. Both images are maximum
intensity projections of 11 optical sections at 2 μm z-spacing. Scale
bar = 100 μm. (For interpretation of the references to colour in this ﬁg-
ure legend, the reader is referred to the web version of this article.)Fluorescent in situ hybridization histochemistry
Multiple-labelling ﬂuorescent in situ hybridisation was per-
formed with RNAscope probes and RNAscope ﬂuorescent
multiplex reagent kit 320,850 (ACD BioTechne; Newark,
CA 94560). Fresh frozen lumbar spinal cord segments from
3 wild-type mice were embedded in OCT mounting medium
and cut into 12 μm thick transverse sections with a cryostat
(Leica CM1950; Leica; Milton Keynes, UK). These weremounted non-sequentially (such that sections on the
same slide were at least 4 apart) onto SuperFrost Plus
slides (48311–703; VWR; Lutterworth, UK) and air dried.
Reactions were carried out according to the manufac-
turer's recommended protocol. The probes used in this
study, and the proteins/peptides that they correspond to,
are listed in Table 2. Sections from 3 mice were incubated
in the following probe combinations: (1) Npff, Grp, Tac1;
(2) Npff, Cck, Tac2; (3) Npff, Nts. Probes were revealed
with Alexa 488 (Npff), Atto 550 (Grp, Cck) and Alexa 647
(Tac1, Tac2 and Nts). Sections were mounted with
Prolong-Glass anti-fade medium with NucBlue (Hoechst
33342) (ThermoFisher Scientiﬁc, Paisley, UK). Positive
and negative control probes were also tested on other
sections (Table 2).
Sections were scanned with a Zeiss LSM 710 confocal
microscope as above. Since the sections reacted with each
probe combination were obtained from a 1 in 4 series, there
was at least 36 μm separation between the scanned sec-
tions. Confocal image stacks were obtained through the
40× oil immersion lens with the confocal aperture set to 1
Airy unit, and the entire mediolateral width of laminae I-II
was scanned to generate a z-series of the full thickness of
the section, with a z-separation of 2 μm. Confocal scans
of 5 sections per animal were analysed with Neurolucida
for Confocal software. Initially, only the channel correspond-
ing to Npff mRNA was examined and all Npff positive
Maria Gutierrez-Mecinas et al. / Neuroscience 416 (2019) 281–293 285NucBlue nuclei were identiﬁed. Then channels correspond-
ing to other probes were viewed and any co-localisation
noted. Cells were deﬁned as positive for a particular mRNA
if greater than 4 transcripts were present in the nucleus or
immediate perinuclear area.Characterization of antibodies
The sources and dilutions of primary antibodies used in the
study are listed in Table 1. The pro-NPFF antibody was
raised against a fusion protein consisting of glutathione S-
transferase and amino acids 22–114 of the mouse pro-
NPFF protein (NCBI, NM_018787). Staining was comple-
tely abolished by pre-incubating the antibody at its normal
working concentration (0.83 μg/ml) with the antigen at
4.4 μg/ml (Fig. 1). The mouse monoclonal antibody NeuN
reacts with a protein in cell nuclei extracted from mouse
brain (Mullen et al., 1992), which has subsequently been
identiﬁed as the splicing factor Fox-3 (Kim et al., 2009). This
antibody apparently labels all neurons but no glial cells in
the rat spinal dorsal horn (Todd et al., 1998). The eGFP anti-
body was raised against recombinant full-length eGFP, and
its distribution matched that of native eGFP ﬂuorescence.
The Pax2 antibody was raised against amino acids
268–332 of the human protein, and it has been shown that
this labels essentially all GABAergic neurons in adult ratFig. 2. Pro-NPFF-immunoreactivity in the dorsal horn and lateral spinal nucle
through the L4 spinal segment of a mouse reacted with antibody against pro-NPF
outline is shown with a solid line and the lamina II-III border with a dashed line.
immunoreactive axons in lamina I and the outer part of lamina II, with scattered
There is also a dense plexus in the lateral spinal nucleus (LSN) (arrow). The box
in B and C. B, C: a higher magniﬁcation view showing the relation of pro-NPFF (g
Two immunoreactive cell bodies are indicated with arrows. Note that the pro-NP
pies the perikaryal cytoplasm, surrounding the nucleus (which is labelled strongl
The images are maximum intensity projection of 23 optical sections (A) or 3 opti
z-separation. Scale bars: A = 50 μm; B,C = 25 μm. (For interpretation of the refe
ure legend, the reader is referred to the web version of this article.)dorsal horn (Larsson, 2017). The somatostatin antiserum
is reported to show 100% cross-reactivity with
somatostatin-28 and somatostatin-25, but none with sub-
stance P, neuropeptide Y, or vasoactive intestinal peptide
(manufacturer's speciﬁcation), and we have shown that
staining with this antibody is abolished by pre-incubation
with 10 μg/ml somatostatin (Proudlock et al., 1993). The
CTb antibody was raised against the puriﬁed protein, and
speciﬁcity is demonstrated by the lack of staining in regions
that did not contain injected or transported tracer. The pERK
antibody detects p44 and p42 MAP kinase (Erk1 and Erk2)
when these are phosphorylated either individually or dually
at Thr202 and Tyr204 of Erk1 or Thr185 and Tyr187 of
Erk2. This antibody does not cross-react with the corre-
sponding phosphorylated residues of JNK/SAPK or of p38
MAP kinase, or with non-phosphorylated Erk1/2 (manufac-
turer's speciﬁcation). Speciﬁcity is demonstrated by the lack
of staining in non-stimulated areas (e.g. in the contralateral
dorsal horn).RESULTS
Pro-NPFF-immunoreactivity in the dorsal horn
Immunoreactivity for pro-NPFF was highly concentrated in
the superﬁcial dorsal horn (laminae I-II) and the LSN, withus. A: transverse section
F (green). The dorsal horn
There is a high density of
proﬁles in deeper laminae.
indicates the area shown
reen) to NeuN (magenta).
FF immunostaining occu-
y with the NeuN antibody).
cal sections (B,C) at 1 μm
rences to colour in this ﬁg-a distribution very similar to that
reported previously in the rat with
antibodies against NPFF (Allard
et al., 1991; Kivipelto and Panula,
1991) (Fig. 2). At high magniﬁca-
tion, most immunoreactive proﬁles
resembled axon terminals, but
there were also labelled cell
bodies, in which the
immunoreactivity was present in
the perikaryal cytoplasm (Fig. 2B
and C). These pro-NPFF-
immunoreactive cell bodies were
present throughout laminae I-II,
but were most numerous in the
dorsal half of this region. They
were not seen in the LSN.
In the quantitative analysis with
the disector technique, we identi-
ﬁed a mean of 392 (range
323–444) NeuN-positive cells in
laminae I-II per mouse (n = 3
mice), and found that 4.74%
(3.83–6.36%) of these were pro-
NPFF-immunoreactive. To test
the prediction that pro-NPFF cells
were excitatory (Häring et al.,
2018), we looked for the presence
of Pax2. This was carried out on
tissue from the GRP-EGFP
mouse, which also allowed us to
determine whether there was any
co-expression of pro-NPFF and
Fig. 3. Lack of co-localisation of pro-NPFF with either Pax2 or eGFP in
the GRP-EGFP mouse. Part of the superﬁcial dorsal horn of a GRP-
EGFP mouse immunostained for pro-NPFF (red) and NeuN (blue),
together with Pax2 and eGFP (both of which are shown in green, in B
and C, respectively). A: Two pro-NPFF-immunoreactive cells are shown
with arrows. These cells are negative for both Pax2 (B) and eGFP (C).
Arrowheads in B and C show cells that are Pax2-immunoreactive (B)
or eGFP-immunoreactive (C). Images are projections of 2 optical sec-
tions at 1 μm z-spacing. Scale bar = 20 μm. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.)
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tissue (50–66, n = 3 mice), and found that none of these
were either Pax2- or eGFP-immunoreactive (Fig. 3). Soma-
tostatin is expressed by many excitatory interneurons in the
superﬁcial dorsal horn (Gutierrez-Mecinas et al., 2016), and
we therefore looked for co-localisation of pro-NPFF- and
somatostatin-immunoreactivity. We identiﬁed 62.7 (56–67)
pro-NPFF-immunoreactive cells in sections from 3 wild-
type mice, and found that 85.3% (81.5–89.3%) of thesewere also immunoreactive for somatostatin (Fig. 4). There
was also extensive co-localisation of pro-NPFF and soma-
tostatin in axonal boutons.
Fluorescence in situ hybridization
The distribution of cells that contained Npff mRNA was the
same as that of cells with pro-NPFF immunoreactivity. They
were largely restricted to the superﬁcial dorsal horn, and
were most numerous in lamina I and the outer part of lamina
II. In sections reacted with probes against Npff, Tac1 and
Grp mRNAs, we identiﬁed 58.7 (51–65) Npff mRNA+ cells
in tissue from each of 3 mice. We found very limited overlap
with Tac1, since only 4.6% (3.3–5.9%) of these cells were
also Tac1 mRNA+ (Fig. 5A, C, D). However, there was
extensive overlap with the mRNA for Grp (Fig. 5A, B, D).
Grp mRNA was found in 38% (28–47%) of Npff mRNA+
cells, and this represented 6.3% (5.3–7.3%) of the Grp
mRNA+ cells in laminae I-II. In the sections reacted for Npff,
Cck and Tac2 mRNAs, we identiﬁed 57 (53–62) Npff
mRNA+ cells from the 3 mice. None of these were positive
for Tac2 mRNA, and only one was positive for Cck mRNA
(corresponding to 0.6% of the Npff population) (Fig. 5E
and F). In sections reacted for Npff and Nts mRNAs, we
found 60.7 (56–68) Npff mRNA+ cells in the 3 mice
(Fig. 5G-I). Only two of these cells were Nts mRNA+ (corre-
sponding to 1% of the Npff population).
Lack of labelling of PNs
We identiﬁed a total of 111 CTb-labelled neurons in lamina I
in the 3 animals that had received injections into the LPb
(29–52 per mouse). None of the CTb-labelled cells were
pro-NPFF-immunoreactive (Fig. 6).
pERK
The distribution of pERK-immunoreactivity in mice that had
received noxious or pruritic stimuli was very similar to that
described previously (Ji et al., 1999; Bell et al., 2016;
Dickie et al., 2019). In each case, pERK-positive cells were
only seen on the side ipsilateral to the stimulus, in the
somatotopically appropriate region of the dorsal horn,
and they were most numerous in the superﬁcial laminae
(I-II) (Fig. 7). Few, if any, pERK+ cells were seen in mice
that had received intradermal injection of vehicle. For each
of the stimuli examined, we found that some pro-NPFF-
immunoreactive cells were pERK-positive (Fig. 7,
Table 3), although in many cases these cells showed rela-
tively weak pERK immunoreactivity (Fig. 7C, F, O). For the
noxious heat stimulus, and for both pruritogens (chloro-
quine, histamine), the proportion of pro-NPFF cells with
pERK was around 30%, while for pinch and capsaicin
injection the proportions were higher (around 50% and
60%, respectively; Table 3).DISCUSSION
Our main ﬁndings are that the pro-NPFF antibody labels a
population of excitatory interneurons in laminae I-II, that
Fig. 4. Co-localisation of pro-NPFF and somatostatin in the superﬁcial dorsal horn. A,B: Part of lamina II scanned to reveal pro-NPFF (red) and somatos-
tatin (SST, green). C: the same ﬁeld scanned to reveal both peptides, together with NeuN (blue). The asterisk shows a cell that contains both pro-NPFF
and somatostatin in its perikaryal cytoplasm, and therefore expresses both peptides. Arrowheads point to varicosities that contain both types of peptide
immunoreactivity, and presumably correspond to axon terminals. The image is from a single optical section. Scale bar = 20 μm. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Maria Gutierrez-Mecinas et al. / Neuroscience 416 (2019) 281–293 287these cells account for nearly 5% of all neurons in this
region, that they are distinct from cells belonging to other
neurochemical populations that have recently been deﬁned
(Gutierrez-Mecinas et al., 2016, 2017, 2019), and that many
of them respond to noxious and/or pruritic stimuli.
Technical considerations
The laminar pattern of staining with the pro-NPFF antibody
closely matched that described previously for NPFF antibo-
dies in rat spinal cord (Allard et al., 1991; Kivipelto and
Panula, 1991), while the immunoreactive cell bodies
showed a similar distribution to that seen with in situ hybridi-
sation using NPFF probes. In addition, the lack of expres-
sion in Pax2-positive cells is consistent with the restriction
of NPFF to excitatory neurons (Häring et al., 2018). Taken
together with the ﬁnding that pre-absorption with the antigen
blocked immunostaining, these observations suggest that
this new antibody was indeed detecting NPFF-expressing
neurons. Further conﬁrmation of its speciﬁcity could be
obtained in the future by testing the antibody on tissue from
NPFF knock-out mice.NPFF cells as a distinct population of excitatory
interneurons
Earlier immunocytochemical and in situ hybridisation stu-
dies have shown a relatively high density of NPFF-
expressing cells and processes in the superﬁcial dorsal
horn of the rodent spinal cord (Allard et al., 1991; Kivipelto
and Panula, 1991; Lee et al., 1993; Panula et al., 1999;
Vilim et al., 1999; Häring et al., 2018), with a distribution
that closely matched that seen with the pro-NPFF antibody
and the Npff mRNA probe in the present study. Häring et
al. (2018) showed that these cells, which mainly repre-
sented their Glut9 cluster, co-expressed the mRNA for
Slc17a6 (which codes for VGLUT2), indicating that these
were excitatory neurons. This accords with our ﬁnding that
pro-NPFF-expressing cells were invariably negative for
Pax2-immunoreactivity, which is present in all inhibitory
neurons in the dorsal horn (Cheng et al., 2004; Larsson,
2017).None of the pro-NPFF-immunoreactive cells were retro-
gradely labelled with CTb that had been injected into the lat-
eral parabrachial area, and since tracer injections into this
region are thought to label virtually all projection neurons
in lamina I (Todd, 2010; Cameron et al., 2015), it is likely
that all of the NPFF cells are excitatory interneurons. We
have previously reported that 76% of neurons in the mouse
superﬁcial dorsal horn are excitatory (Pax2-negative)
(Polgár et al., 2013), and since we found pro-NPFF-
immunoreactivity in 4.7% of lamina I-II neurons, we estimate
that the NPFF-expressing cells account for around 6% of all
excitatory neurons in this region. Our ﬁnding that the NPFF
population showed virtually no overlap with those deﬁned
by expression of Cck, Nts or Tac2, and only minimal overlap
with the Tac1 population is consistent with the ﬁndings of
Haring et al., since these cells would correspond to those
belonging to Glut1–3 (Cck), Glut4 (Nts), Glut5–7 (Tac2) and
Glut10–11 (Tac1). We have also examined sections that
had been immunostained for pro-NPFF together with various
combinations of antibodies against neurotensin, preprotachy-
kinin B (the precursor for NKB) and pro-cholecystokinin (the
precursor for CCK), and found no overlap of any of these with
pro-NPFF (M Gutierrez-Mecinas and AJ Todd, unpublished
data). With regard to GRP, there was an apparent discre-
pancy, since we found no overlap between pro-NPFF-
immunoreactivity and eGFP expression in the GRP-EGFP
mouse, but nearly 40% of the Npff mRNA+ cells also con-
tained Grp mRNA. By using multiple-label ﬂuorescent in situ
hybridisation we have found that although all Gfp mRNA+
cells in this mouse line contain Grp mRNA, these only
account for around 25% of the Grp mRNA+ cells (AM Bell,
unpublished observations). Interestingly, Häring et al.
reported that Grp mRNA was widely distributed among sev-
eral excitatory interneuron clusters (Glut5–12), whereas we
have found that the GRP-eGFP-positive cells in lamina II
form a relatively homogeneous population that shows very lit-
tle overlap with neurons that express CCK, neurotensin, sub-
stance P or NKB (Gutierrez-Mecinas et al., 2016, 2019.
Dickie et al., 2019). In addition, these cells show a unique
somatotopic distribution, as they are far less frequent in
regions that are innervated from glabrous skin (Dickie et al.,
2019). This suggests that the GRP-eGFP cells represent a
Fig. 5. Fluorescence in situ hybridisation for Npff and other neuropeptides. A-C show part of lamina II in a section reacted with probes for Npff (red), Grp
(green) and Tac1 (blue) mRNAs. D is the same ﬁeld, which has been scanned to reveal the nuclear counterstain NucBlue (grey). Two Npff mRNA+ cells
are indicated with arrows. These are both positive for Grp mRNA, but negative for Tac1 mRNA. Another cell with Grp mRNA only is shown with a single
arrowhead, and two Tac1 mRNA+ cells (which lack Npff and Grp mRNAs) are indicated with double arrowheads. E: part of laminae I and II scanned to
reveal mRNAs for Npff (red), Cck (green) and Tac2 (blue). F: the same section also showing NucBlue (grey). Three Npff mRNA+ cells are indicated with
arrows, and these lack mRNAs for Cck or Tac2. Examples of cells with mRNA for Cck and Tac2 are shown with single and double arrowheads, respec-
tively. G,H show part of laminae I and II scanned to reveal mRNAs for Npff (red) and Nts (green). I: The same ﬁeld also showing NucBlue (grey). Two Npff
mRNA+ cells are indicated with arrows, and two Nts mRNA+ cells with arrowheads. All images were projected from 2 optical sections at 2 μm z-separa-
tion. Scale bar = 20 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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far more widely expressed.
We have previously estimated that the other neurochem-
ical populations that we have identiﬁed (those that express
neurokinin B, neurotensin, CCK, substance or GRP-eGFP)
account for around two-thirds of the excitatory neurons in
laminae I-II (Gutierrez-Mecinas et al., 2016, 2019; Dickie
et al., 2019). With our ﬁnding that the NPFF population
accounts for ~6% of excitatory neurons, this brings the totalthat can be assigned to one of these populations to ~75% of
these cells (Fig. 8).The role of NPFF
Neuropeptide FF was initially isolated from bovine brain-
stem and characterised by Yang et al. (1985). The gene
encoding the precursor protein pro-NPFF was subsequently
identiﬁed and sequenced, and shown to code for both NPFF
Fig. 6. Lack of pro-NPFF in lamina I projection neurons. A,B: part of lamina I from a mouse that had received an injection of cholera toxin B subunit (CTb)
into the lateral parabrachial area on the contralateral side. A cell with pro-NPFF-immunoreactivity is indicated with an arrow, and a nearby CTb-labelled
lamina I projection neuron with an arrowhead. C: merged image showing the two cells. The dashed line represents the dorsal border of lamina I. The
image is a projection of 3 optical sections at 1 μm z-separation. Scale bar = 20 μm.
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et al., 1997). Initial studies demonstrated that intracerebro-
ventricular injection of NPFF suppressed morphine analge-
sia (Yang et al., 1985). However, Gouarderes et al. (1993)
reported that intrathecal NPFF caused a prolonged increase
in both tail-ﬂick latency and paw pressure threshold in rats,
corresponding to an analgesic effect. In addition, NPFF
enhanced the analgesic action of intrathecal morphine. A
subsequent study suggested that the anti-nociceptive
action of spinal NPFF involved both μ and δ opioid recep-
tors, since it was reduced by co-administration of speciﬁc
antagonists acting at both of these classes of opioid recep-
tors, while sub-effective doses of NPFF analogues
enhanced the effect of both μ and δ opioid agonists admi-
nistered intrathecally (Gouarderes et al., 1996).
Two G protein-coupled receptors for NPFF have been
identiﬁed, and named NPFF-R1 and NPFF-R2 (Bonini et
al., 2000; Elshourbagy et al., 2000; Hinuma et al., 2000).
These both couple to G proteins of the Gi family (Ayachi
and Simonin, 2014). NPFF-R2 is highly expressed in the
spinal dorsal horn, as shown by both in situ hybridisation
(Liu et al., 2001) and RT-PCR (Bonini et al., 2000; Yang
and Iadarola, 2003), and the mRNA is also present in dorsal
root ganglia (Bonini et al., 2000). This suggests that NPFF
released from excitatory interneurons acts on NPFF-R2
expressed by both primary afferents and dorsal horn neu-
rons (Yang et al., 2008). Primary afferents with mRNA for
NPFF-R2 include those that express TRPM8 or MrgA3
(which are likely to be cold-sensitive and pruritoceptive,
respectively) as well as peptidergic nociceptors (Zeisel et
al., 2018). The anti-nociceptive action of NPFF is thought
to involve opening of voltage-dependent potassium chan-
nels in primary afferent neurons (Mollereau et al., 2011).
However, little is apparently known about the types of dorsal
horn neuron that express the receptor. Binding sites for
NPFF have also been identiﬁed in human spinal cord, with
the highest levels in the superﬁcial dorsal horn (Allard et
al., 1994). This suggests that NPFF may also modulate
nociceptive transmission in humans.
There is also evidence that expression of both NPFF and
the NPFF-R2 are up-regulated in inﬂammatory, but not neu-
ropathic, pain states (Kontinen et al., 1997; Vilim et al.,
1999; Yang and Iadarola, 2003), and it has been suggestedthat this may contribute to the enhanced analgesic efﬁcacy
of morphine in inﬂammatory pain (Hylden et al., 1991; Yang
et al., 2008).Function of Npff cells
Häring et al. (2018) used expression of the immediate early
gene Arc (which codes for activity-regulated cytoskeleton-
associated protein) to assess activation of their neuronal
populations in response to noxious heat and cold stimuli.
They reported that cells belonging to the Glut9 cluster
(which correspond to the NPFF-expressing excitatory inter-
neurons) could upregulate Arc following both types of stimu-
lus, with ~10% of these cells showing increased Arc mRNA
after noxious heat. Our ﬁndings extend these observations,
by showing that many NPFF cells were pERK-positive (and
therefore activated), not only following noxious heat, but
also after other noxious (pinch, capsaicin) and pruritic (his-
tamine, chloroquine) stimuli. We have previously reported
that among all neurons in laminae I-II, between 20 and
37% show pERK-immunoreactivity with the different stimuli
that were used in this study (Table 3) (Bell et al., 2016;
Dickie et al., 2019). Comparison with the results for the
NPFF cells, suggests that for most of the stimuli the NPFF
cells were at least as likely to show pERK as other neurons
in this region, while in the case of pinch and capsaicin they
appear to be more likely to be activated. Since each experi-
ment involved only a single type of stimulus, we cannot
determine whether there was convergence of different types
of nociceptive, or of nociceptive and pruritoceptive inputs
onto individual cells. The proportions that we identiﬁed as
being pERK-positive are therefore likely to have underesti-
mated the fraction of cells that respond to one or more of
these stimuli.
Since the NPFF cells are glutamatergic interneurons, their
main action is presumably through glutamatergic synapses
with other dorsal horn cells. Part of the NPFF axonal plexus
lies in lamina I, where it may target ALT projection cells. In
addition, the NPFF axons that enter the LSN have been
shown to form contacts with spinothalamic neurons in this
region in the rat (Aarnisalo and Panula, 1998), although
synaptic connections were not identiﬁed in that study. How-
ever, many of the NPFF axons remain in lamina II, where
Fig. 7. Phosphorylation of extracellular signal-regulated kinases in NPFF-expressing neurons. Each row shows part of the superﬁcial dorsal horn immu-
nostained for pro-NPFF (green; A,D,G,J,M), pERK (magenta; B,E,H,K,N) together with a merged image (C,F,I,L,O), following pinch (A-C), noxious heat
(D-F), intraplantar capsaicin (G-I), intradermal histamine (J-L) or intradermal chloroquine (M-O). Pro-NPFF cells that are pERK+ are indicated with
arrows, and those that lack pERK with arrowheads. Note that some of the pro-NPFF cells show relatively weak pERK immunoreactivity. Images are from
single optical sections (G-I) or from maximum projections of 2 (A-C, J-L, M-O) or 3 (D-F) optical sections at 1 μm z-separation. Scale bar = 20 μm. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Table 3. NPFF cells that were pERK positive following noxious or pruri-
tic stimuli.
Stimulus NPFF+
neurons
NPFF+
and
pERK+
% NPFF
neurons
pERK+
% of all neurons
in laminae I-II with
pERK
Pinch 82.3
(71–92)
41.6
(26–50)
49.8%
(36.6–58.3%)
37%
Noxious
heat
104.7
(102–110)
31.7
(27–39)
30.1%
(26.5–35.5%)
23%
Capsaicin 90
(80–102)
55.7
(50–63)
62%
(56.8–67.5%)
27%
Histamine 91
(76–109)
30
(28–34)
33.3%
(31.5–36.8%)
33%
Chloroquine 114.3
(95–132)
37.7
(27–56)
32.2%
(25.9–42.4%)
21%*
Column 2–4 show the number of NPFF cells identiﬁed within the zone that showed
pERK, the number of NPFF/pERK double-labelled cells, and the proportion of
NPFF cells with pERK, respectively. The 5th column shows the proportion of all
neurons in laminae I-II that were found to be pERK-immunoreactive with equivalent
stimuli in previous studies (Bell et al., 2016; Dickie et al., 2019). *Note that the pro-
portion of laminae I-II neurons that were pERK+ after chloroquine (21%) was esti-
mated in experiments involving a lower dose of chloroquine (40 μg) than that used
in the present study (100 μg) (Bell et al., 2016).
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(Todd, 2010). It is therefore likely that they engage in com-
plex synaptic circuits that transmit nociceptive and prurito-
ceptive information (Peirs and Seal, 2016; Huang et al.,
2018). Cells in laminae IIi-III that express PKCγ are thought
to form part of a polysynaptic pathway that can convey low-
threshold mechanoreceptive inputs to nociceptive projec-
tion neurons in lamina I under conditions of disinhibition,
and thus contribute to tactile allodynia (Lu et al., 2013).
However, much less is known about the roles of excitatory
interneurons in circuits that underlie acute mechanical or
thermal pain, or those that are responsible for hyperalgesia
in either inﬂammatory or neuropathic pain states.
Interestingly, we found that the great majority of the NPFF
cells were somatostatin-immunoreactive, and are thereforeFig. 8. Pie chart showing the relative sizes of different neurochemical
populations among the excitatory interneurons in laminae I-II of the
mouse dorsal horn. Note that the neurokinin B (NKB), neurotensin
(NTS), cholecystokinin (CCK), substance P, NPFF and GRP-eGFP
cells form largely non-overlapping populations, although there is some
overlap between NKB/NTS and CCK/substance P populations. Protein
kinase Cγ (PKCγ) is expressed by many of the NTS, and some of the
NKB and CCK cells. The pie chart is based on quantitative data from
the present study and from previous studies (Gutierrez-Mecinas et al.,
2016, 2019; Dickie et al., 2019).likely to have been affected in previous studies that manipu-
lated the function of somatostatin-expressing dorsal horn
neurons (Duan et al., 2014; Christensen et al., 2016). Since
these studies implicated somatostatin cells in acute
mechanical pain, as well as tactile allodynia in neuropathic
and inﬂammatory pain states, our ﬁnding suggests that
NPFF cells may contribute to these forms of pain. The
somatostatin released by NPFF neurons that were activated
by intradermal injection of pruritogens may be involved in
itch, since somatostatin released from dorsal horn interneur-
ons is thought to cause itch by a disinhibitory mechanism
involving inhibitory interneurons that express the somatos-
tatin 2a receptor (Huang et al., 2018). Assessing the roles
of NPFF cells in spinal pain and itch mechanisms will
require a method for selectively targeting them, presumably
involving a genetically altered mouse line in which NPFF
cells express a recombinase.
These results show that NPFF is expressed by a distinct
population that accounts for around 6% of the excitatory
interneurons in laminae I and II, and that these cells are fre-
quently activated by noxious or pruritic stimuli.
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